Table 1 Patient demographic and clinical characteristics
Full population (excluding those with regular visits) (n = 20,041) | Regular visits sub-cohort (n = 9812) | |
|---|---|---|
Age, mean years (SD) | 57.9 (13.4) | 59.3 (13.5) |
Sex, n female (%) | 15,193 (76.3) | 7360 (75.8) |
Duration of RA, mean years (SD) | 9.1 (9.7) | 8.7 (9.7) |
Disabled, n (%) | 2439 (12.3) | 1072 (11.1) |
Patient paina, mean score (SD) | 34.6 (27.7) | 33.6 (27.8) |
TJC28, mean n (SD) | 4.6 (6.2) | 4.1 (5.8) |
SJC28, mean n (SD) | 4.5 (5.6) | 3.6 (5.0) |
PtGA, mean score (SD) | 32.0 (26.7) | 30.9 (26.6) |
PGA, mean score (SD) | 25.7 (21.9) | 23.5 (21.5) |
CDAI, mean score (SD) | 14.8 (13.3) | 13.0 (12.6) |
CDAI category, n (%) | ||
Low (score >2.8 to ≤10) | 9435 (47.1) | 5269 (53.7) |
Moderate (score >10 to ≤22) | 5674 (28.3) | 2634 (26.8) |
Severe (score >22) | 4929 (24.6) | 1909 (19.5) |
History of biologic DMARD use, n (%) | 9411 (47.0) | 4485 (45.7) |